The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
How COVID-19 Affects the Brain
Open accessAbstract
COVID-19 has resulted in more than 120 million cases and 2.6 million deaths to date.Respiratory and gastrointestinal symptoms are accompanied by short-and long-term neuropsychiatric symptoms (NPs) and long-term brain sequelae.Some patients present with anosmia, cognitive and attention deficits (ie, brain fog), new-onset anxiety, depression, psychosis, seizures, and even suicidal behavior. 1,2These present before, during, and after respiratory symptoms and are unrelated to respiratory insufficiency, 1 suggesting independent brain damage.Follow-ups conducted in Germany and the United Kingdom found post-COVID-19 NPs in 20% to 70% of patients, even in young adults, and lasting months after respiratory symptoms resolved, 1 suggesting brain involvement persists.Entering through angiotensin-converting enzyme 2 receptors, 2 SARS-CoV-2 can damage endothelial cells leading to inflammation, thrombi, and brain damage.Moreover, systemic inflammation leads to decreased monoamines and trophic factors and activation of microglia, resulting in increased glutamate and N-methyl-D-aspartate (NMDA) 3 and excitotoxicity (Figure).These insults induce newonset or re-exacerbation of preexisting NPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Meinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., Laue, M., Schneider, J., Brünink, S., Greuel, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00758-5 · Cited by 1,458
A complement–microglial axis drives synapse loss during virus-induced memory impairment
Vasek, M. J., Garber, C., Dorsey, D., Durrant, D. M., Bollman, B., Soung, A., Yu, J., Perez-Torres, C., Frouin, A., Wilton, D. K., et al. (2016) · Nature · doi:10.1038/nature18283 · Cited by 671
Self-citationFrequent neurocognitive deficits after recovery from mild COVID-19
Woo, M. S., Malsy, J., Pöttgen, J., Seddiq Zai, S., Ufer, F., Hadjilaou, A., Schmiedel, S., Addo, M. M., Gerloff, C., Heesen, C., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa205 · Cited by 394
Daniels, B. P., Holman, D. W., Cruz-Orengo, L., Jujjavarapu, H., Durrant, D. M., & Klein, R. S. (2014) · mBio · doi:10.1128/mbio.01476-14 · Cited by 235
Self-citationAltered neuro-inflammatory gene expression in hippocampus in major depressive disorder
Mahajan, G. J., Vallender, E. J., Garrett, M. R., Challagundla, L., Overholser, J. C., Jurjus, G., Dieter, L., Syed, M., Romero, D. G., Benghuzzi, H., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.017 · Cited by 159
Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage
Al‐Dalahmah, O., Thakur, K. T., Nordvig, A. S., Prust, M., Roth, W., Lignelli, A., Uhlemann, A., Miller, E. H., Kunnath-Velayudhan, S., Portillo, A. D., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01024-2 · Cited by 144
Self-citationNovel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far
Roman, M., & Irwin, M. R. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.09.016 · Cited by 132
Boldrini, M., Galfalvy, H., Dwork, A. J., Rosoklija, G. B., Trencevska-Ivanovska, I., Pavlovski, G., Hen, R., Arango, V., & Mann, J. J. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.022 · Cited by 116
Self-citationTraumatic Brain Injury and Suicidal Behavior: A Review
Wadhawan, A., Stiller, J. W., Potocki, E., Okusaga, O. O., Dagdag, A., Lowry, C. A., Benros, M. E., & Postolache, T. T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181055 · Cited by 41
Cited by
Long-term neurologic outcomes of COVID-19
Xu, E., Xie, Y., & Al-Aly, Z. (2022) · Nature Medicine · doi:10.1038/s41591-022-02001-z · Cited by 530
Long-term effects of COVID-19 on mental health: a systematic review
Bourmistrova, N. W., Solomon, T., Braude, P., Strawbridge, R., & Carter, B. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.11.031 · Cited by 369
“Reports of effects on the brain include inflammation which have been linked with cognitive deficits and psychiatric manifestations (Boldrini et al., 2021).”
BackgroundZeng, N., Zhao, Y.-M., Yan, W., Li, C., Lu, Q.-D., Liu, L., Ni, S.-Y., Mei, H., Yuan, K., Shi, L., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01614-7 · Cited by 330
Association of COVID-19 with New-Onset Alzheimer’s Disease
Wang, L., Davis, P. B., Volkow, N. D., Berger, N. A., Kaelber, D. C., & Xu, R. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220717 · Cited by 178
Uncovering survivorship bias in longitudinal mental health surveys during the COVID-19 pandemic
Czeisler, M. É., Wiley, J. F., Czeisler, C. A., Rajaratnam, S. M. W., & Howard, M. E. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579602100038x · Cited by 90
Metadata
- Authors
- Boldrini, M., Canoll, P. D., & Klein, R. S.
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2021-06-01
- Volume
- 78
- Issue
- 6
- Pages
- 682
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W3139445795
- Cited by
- 427
- References
- 10
- FWCI
- 37.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How COVID-19 Affects the Brain. https://app.cochat.ai/papers/10.1001/jamapsychiatry.2021.0500
- The paper
- Boldrini, M., Canoll, P. D., & Klein, R. S. (2021). How COVID-19 Affects the Brain. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2021.0500
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.